Immune checkpoint inhibitor therapy for gastric cancer: current status, therapeutic challenges, and future prospects

Gastric cancer is among the most prevalent malignant tumors of the digestive system worldwide. In recent years, immune checkpoint inhibitors (ICIs) have achieved substantial advances in the treatment of gastric cancer. By blocking the PD-1/PD-L1 and CTLA-4 signaling pathways, ICIs enhance antitumor...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Penghui Liu, Na Li, Jiwu Guo, Gengyu Tong Zhao, Jizhen Wang, Ziyuan Mou, Jie Mao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-02-01
coleção:	Frontiers in Immunology
Assuntos:	efficacy and safety gastric cancer immune checkpoint inhibitors immunotherapy personalized treatment
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1716934/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!